Document is current
Any future updates will be listed below
-
Authors
Palumbo, Francesca
Iazzolino, Barbara
Moglia, Cristina
Manera, Umberto
Matteoni, Enrico
Cabras, Sara
Brunetti, Maura
Gallone, Salvatore
Callegaro, Stefano
Vasta, Rosario
Mora, Gabriele
De Marchi, Fabiola
Corrado, Lucia
D’Alfonso, Sandra
Mazzini, Letizia
Canosa, Antonio
Grassano, Maurizio
Calvo, Andrea
Chiò, Adriano https://orcid.org/0000-0001-9579-5341
-
Funding
Funding for this research was provided by:
Ministero della Salute (RF-2016-02362405)
Ministero dell'Università e della Ricerca (2017SNW5MB, 20228N7573)
Seventh Framework Programme (259867)
H2020 Health (101017598)
HORIZON EUROPE Framework Programme (101137074)
ARISLA (DIG-ALS)
- License Information
-
More Information
Article History
Received: 24 May 2025
Revised: 11 July 2025
Accepted: 14 July 2025
First Online: 21 July 2025
Declarations
:
: Adriano Chiò serves on scientific advisory boards for Mitsubishi Tanabe, Biogen, Roche, Denali Pharma, Cytokinetics, Lilly, Ferrer, Zambon Biotech, and Amylyx Pharmaceuticals, and has received a research grant from Biogen. Francesca Palumbo, Barbara Iazzolino, Cristina Moglia, Umberto Manera, Enrico Matteoni, Sara Cabras, Maura Brunetti, Salvatore Gallone, Rosario Vasta, Gabriele Mora, Antonio Canosa, Maurizio Grassano do not report any conflict of interest. Andrea Calvo has received a research grant from Cytokinetics.
